We are live on ! Find out more
OMCL icon

Omnicell

174 hedge funds and large institutions have $948M invested in Omnicell in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 71 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

13% more capital invested

Capital invested by funds: $841M → $948M (+$106M)

0% more funds holding

Funds holding: 174174 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

15% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 71

57% less call options, than puts

Call options by funds: $281K | Put options by funds: $658K

Holders
174
Holders Change
Holders Change %
0%
% of All Funds
5.01%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
60
Reduced
71
Closed
16
Calls
$281K
Puts
$658K
Net Calls
-$377K
Net Calls Change
-$313K

OMCL Hedge Fund Activity: Q1 2014 in Review

174 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q1 2014, worth a combined $948M — up 13% from $841M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new OMCL positions and 16 closed out — a net gain of 3 holders — while 60 added to existing stakes and 71 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $9.57M. The largest seller was JP Morgan Chase, cutting an estimated $8.55M.

  • 174 institutional investors held Omnicell (OMCL) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $948M of Omnicell stock for Q1 2014, up 13% quarter-over-quarter.
  • 19 funds opened new Omnicell positions in Q1 2014 and 16 closed out, a net change of +3 holders.
  • The largest Omnicell buyer in Q1 2014 was Fidelity Investments, an estimated $9.57M added.
  • The largest Omnicell seller in Q1 2014 was JP Morgan Chase, an estimated $8.55M sold.

Based on aggregated 13F filings for Q1 2014.